MedTrace Logo

One Hour Preoperative Gatifloxacin

NCT00350363 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-01-29

Study results available
· View outcomes & findings →

Summary

Comparison of 1 day versus 1 hour application of topical Zymar.

Conditions

  • Ophthalmic Surgery

Interventions

DRUG

Zymar

zymar qid

Sponsors & Collaborators

Principal Investigators

  • Christopher Ta, MD · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350363 on ClinicalTrials.gov